T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Olin
OLN
$2.17B
| $25.8M | ﹤0.01% |
761,812
-5,201
| -0.7% | -$217K |
|
|
ORKA
927
Oruka Therapeutics
ORKA
$7.16B
| $25.7M | ﹤0.01% |
1,326,893
+1,047,245
| +374% | +$25.5M |
|
928
Invitation Homes
INVH
$18B
| $25.6M | ﹤0.01% |
801,119
-3,664
| -0.5% | -$122K |
|
929
10x Genomics
TXG
$7.58B
| $25.6M | ﹤0.01% |
1,781,268
-734,635
| -29% | -$11.6M |
|
930
Snap-on
SNA
$20.9B
| $25.6M | ﹤0.01% |
75,308
+770
| +1% | +$260K |
|
931
Tarsus Pharmaceuticals
TARS
$3.02B
| $25.5M | ﹤0.01% |
460,773
+221,458
| +93% | +$10.1M |
|
932
Viridian Therapeutics
VRDN
$2.49B
| $25.4M | ﹤0.01% |
1,326,811
+1,281,799
| +2,848% | +$27.9M |
|
933
Mid-America Apartment Communities
MAA
$15.6B
| $25.4M | ﹤0.01% |
164,112
+504
| +0.3% | +$78.7K |
|
|
CPRX
934
DELISTED
Catalyst Pharmaceutical
CPRX
| $25.4M | ﹤0.01% |
1,215,438
-18,945
| -2% | -$407K |
|
935
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $25.2M | ﹤0.01% |
97,681
-2,730
| -3% | -$732K |
|
936
Estee Lauder
EL
$31.6B
| $25.1M | ﹤0.01% |
334,679
-470,284
| -58% | -$37.1M |
|
937
W.R. Berkley
WRB
$26.2B
| $25M | ﹤0.01% |
427,680
+352
| +0.1% | +$21.1K |
|
938
Trimble
TRMB
$13.4B
| $25M | ﹤0.01% |
353,645
+470
| +0.1% | +$32K |
|
939
Vital Farms
VITL
$498M
| $25M | ﹤0.01% |
662,174
+239,552
| +57% | +$8.52M |
|
940
Valvoline
VVV
$4.31B
| $25M | ﹤0.01% |
689,726
-193,743
| -22% | -$7.75M |
|
941
Modine Manufacturing
MOD
$10.8B
| $25M | ﹤0.01% |
215,230
+174,862
| +433% | +$22.5M |
|
942
Celestica
CLS
$43.8B
| $24.9M | ﹤0.01% |
269,378
+106,931
| +66% | +$8.36M |
|
943
Mueller Industries
MLI
$14.7B
| $24.7M | ﹤0.01% |
621,648
+406,106
| +188% | +$16.5M |
|
944
Photronics
PLAB
$1.97B
| $24.4M | ﹤0.01% |
1,033,690
-70,760
| -6% | -$1.73M |
|
945
Academy Sports + Outdoors
ASO
$3.03B
| $24.3M | ﹤0.01% |
421,719
+3,756
| +0.9% | +$198K |
|
946
Immunome
IMNM
$3B
| $24.2M | ﹤0.01% |
2,282,754
+246,447
| +12% | +$2.98M |
|
947
Gulfport Energy Corp
GPOR
$3.01B
| $24.2M | ﹤0.01% |
131,476
+479
| +0.4% | +$76.9K |
|
948
First Industrial Realty Trust
FR
$8.4B
| $24.2M | ﹤0.01% |
482,850
-136,669
| -22% | -$7.25M |
|
949
Service Corp International
SCI
$11.3B
| $24.1M | ﹤0.01% |
302,224
-9,277
| -3% | -$759K |
|
950
FormFactor
FORM
$10.3B
| $24M | ﹤0.01% |
544,891
-138
| -0% | -$5.93K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.